Answers are grounded in this paper and cite their sources.
Aim This study aims to investigate the dynamic changes in the symptom networks of ovarian cancer patients undergoing postoperative chemotherapy, thereby providing evidence-based support for precision symptom management. Methods A longitudinal study design was adopted. A total of 252 patients with ovarian cancer who were receiving postoperative chemotherapy were enrolled from August 2025 to August 2026. Assessments were performed after the first (T1), third (T3), and sixth (T6) chemotherapy cycles. Symptom severity was assessed using the MD Anderson Symptom Inventory (MDASI) and the tailored symptom module for ovarian cancer (TSM-OC). Contemporaneous networks and cross-lagged panel networks were constructed. Bootstrap-derived correlation-stability (CS) coefficients were calculated to evaluate network stability. Results Contemporaneous network analyses revealed prominent stage-specific shifts in core symptoms: somatic gastrointestinal symptoms predominated at T1, whereas psychological-emotional symptoms occupied the central position of the network at T6. For cross-lagged panel networks, In-strength of the T3→T6 window exhibited excellent stability (CS = 0.595). The top-four symptoms ranked by In-strength were irritability, distress, anxiety, and insomnia. Conclusion Symptom networks among ovarian cancer patients receiving postoperative chemotherapy exhibited distinct stage-specific evolution. Psychological-emotional symptoms in late-phase chemotherapy were temporally preceded by somatic symptoms. Clinically, stage-specific and individualized symptom-management strategies should be implemented.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: